業績｜論文・出版物｜目次｜
2010
Induction of type I interferon by adenovirus-encoded small RNAs
Yamaguchi T., Kawabata K., Kouyama E., Ishii K.J., Katayama K., Suzuki T., Kurachi S., Sakurai F., Akira S., Mizuguchi H.
Proc. Natl. Acad. Sci. USA, 107, 17286-17291 (2010)
Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35
Sakurai, F., Nakashima, K., Yamaguchi, T., Ichinose, T., Kawabata, K., Hayakawa, T., and Mizuguchi, H.
J. Control. Release, 148, 212-218 (2010)
Adenovirus vector-mediated efficient transduction into human embryonic and induced pluripotent stem cells
Tashiro K., Kawabata K., Inamura M., Takayama K., Furukawa N., Sakurai F., Katayama K., Hayakawa H., Furue-Kusuda M., Mizuguchi H.
Cell. Reprogram., 12, 501-507 (2010)
Optimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancer
Eto Y., Yoshioka Y., Ishida T., Yao X., Morishige T., Narimatsu S., Mizuguchi H., Mukai Y., Okada N., Kiwada H., Nakagawa S.
Biol. Pharm. Bull., 33, 1540-1544 (2010)
Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectors
Ushitora M., Sakurai F., Yamaguchi T., Nakamura S-I., Kondoh M., Yagi K., Kawabata K., Mizuguchi H.
J. Control. Release, 142, 431-437 (2010)
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Watanabe Y., Kojima T., Kagawa S., Uno F., Hashimoto Y., Kyo S., Mizuguchi H., Tanaka N., Kawamura H., Ichimaru D., Urata Y., Fujiwara T.
Oncogene, 29, 1145-1154 (2010)
A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer
Van Geer M.A., Brevoord D., Kuhlmann K.F., Bakker C.T., Mizuguchi H., Wesseling J.G., Ten Kate F.J., Gouma D.J., Oude Elferink R.P., Bosma P.J.
Int. J. Oncol., 36, 233-44 (2010)
Comparison of the anti-tumor activity of native, secreted, and membrane-bound LIGHT in mouse tumor models
Morishige T., Yoshioka Y., Tanabe A., Yao X., Mizuguchi H., Tsunoda S., Tsutsumi Y., Mukai Y., Okada N., Nakagawa S.
Int. Immunopharmacol., 10, 26-33 (2010)
In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific oncolytic virotherapy
Kojima T., Watanabe Y., Hashimoto Y., Kuroda S., Yamasaki Y., Yano S., Ouchi M., Tazawa H., Uno F., Kagawa S., Kyo S., Mizuguchi H., Urata Y., Tanaka N., Fujiwara T.
Ann. Surg., 251, 1079-1086 (2010)
Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus
Akita H., Enoto K., Masuda T., Mizuguchi H., Tani T., Harashima H.
Mol. Ther., 18, 955-964 (2010)
Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells
Yashima S., Yoshizaki S., Shinoda K., Yoshida A., Kondo A., Mizuguchi H., Ryo A., Okuda K., Shimada M.
Vaccine, 28, 3257-3264 (2010)
Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin
Kakutani H., Kondoh M., Saeki R., Fujii M., Watanabe Y., Mizuguchi H., Yagi K.
Eur. J. Pharm. Biopharm., 75, 213-217 (2010)
Adenovirus vector covalently conjugated to polyethylene glycol with a cancer-specific promoter suppresses the tumor growth through systemic administration
Yao X., Yoshioka Y., Morishige T., Eto Y., Narimatsu S., Mizuguchi H., Mukai Y., Okada N., Nakagawa S.
Biol. Pharm. Bull., 35, 1073-1076 (2010)